The site manufactures oral drug product to 8 different countries and regions. It offers oral solid drug product manufacturing, along with packaging and labeling capabilities.
In the next 2-3 years, we plan to double the current manufacturing and packaging capacities. The site will also add injectable manufacturing lines, lipid nanoparticle capabilities, and spray dried dispersion.
Our Couvet site has successfully passed numerous inspections by the US FDA, Japan’s PMDA, and SwissMedic.
